Michele M. Oshman is Senior Vice President and Head of Patient Advocacy at BIO. In her role, Michele leads BIO’s engagement with the patient advocacy community, supports BIO member companies’ patient advocacy and engagement needs, and ensures BIO’s policies reflect patient perspectives.
Michele joined BIO in January 2020 after a successful 18-year career at Eli Lilly and Company, where she led federal alliance development outreach. She started her career as a clinical neuroscience researcher and served in multiple clinical development and corporate leadership roles.
From 2012 to 2015, Michele served as Chair of the Biotechnology Innovation Organization Alliance Committee and held the same position with the PhRMA Alliance Development Section in 2016. She chaired the Arthritis Foundation Industry Forum from 2014 to 2016, and currently co-chairs the Lupus Foundation of America corporate council and serves on the Board of Directors for the National Health Council (NHC).
An active member of the Japan America Society of Washington DC, Michele graduated from American University with a dual degree in Political Science and Communications. She has two amazing adult children, a loving husband of over 25 years, and one oversized dog.